MXCT
MAXCYTE, INC.
Company overview
- Market capitalization
- $119.72M
- Employees
- 91
- Latest publication
- 2026-09-29
About MAXCYTE, INC.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company has strategic partnership with VectorBuilder focused on co-developing a new gene delivery solution. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q3 20212021-09-30 · USD | Q2 20212021-06-30 · USD | Q1 20212021-03-31 · USD | Q4 20202020-12-31 · USD | Q3 20202020-09-30 · USD | Q2 20202020-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7,271,000USD | 6,829,000USD | 10,139,100USD | 7,108,100USD | 6,494,900USD | 8,514,000USD | 6,762,600USD | 5,150,400USD |
| Cost Of Revenue | 1,675,000USD | 516,000USD | 943,800USD | 784,500USD | 693,100USD | 906,900USD | 734,800USD | 466,300USD |
| Gross Profit | 5,596,000USD | 6,313,000USD | 9,195,300USD | 6,323,600USD | 5,801,800USD | 7,607,100USD | 6,027,800USD | 4,684,100USD |
| Research Development | 4,253,000USD | 5,316,000USD | 2,746,900USD | 3,203,900USD | 6,076,300USD | 4,891,500USD | 4,517,900USD | 4,090,400USD |
| Selling General Administrative | 7,258,000USD | 6,028,000USD | 5,346,700USD | 4,301,100USD | 2,997,900USD | 2,701,400USD | 2,313,200USD | 1,594,400USD |
| Selling And Marketing Expenses | 3,364,000USD | 3,936,000USD | 3,211,500USD | 2,912,900USD | 2,789,100USD | 2,395,700USD | 2,039,000USD | 1,843,900USD |
| General And Administrative Expenses | 7,258,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 15,828,000USD | 16,885,000USD | 11,638,200USD | 10,740,800USD | 12,174,900USD | 9,988,600USD | 8,870,100USD | 7,528,700USD |
| Operating Income | -10,232,000USD | -10,572,000USD | -2,442,900USD | -4,417,200USD | -6,373,100USD | -2,381,500USD | -2,842,300USD | -2,844,600USD |
| Total Other Income Expense Net | 1,358,000USD | -1,844,000USD | -237,500USD | -4,600USD | -732,500USD | -270,200USD | -256,400USD | -159,500USD |
| Interest Income | 1,358,000USD | 1,733,000USD | 51,500USD | 8,600USD | 9,800USD | 10,400USD | 6,800USD | 5,200USD |
| Income Before Tax | -8,874,000USD | -12,416,000USD | -2,680,400USD | -4,421,800USD | -7,105,600USD | -2,651,700USD | -3,098,700USD | -3,004,100USD |
| Income Tax Expense | 0USD | — | 51,500USD | 8,600USD | 9,800USD | 10,400USD | 6,800USD | -251,300USD |
| Net Income | -8,874,000USD | -12,416,000USD | -2,680,400USD | -4,421,800USD | -7,105,600USD | -2,651,700USD | -3,098,700USD | -3,004,100USD |
| Unclassified Operating Expenses | — | 1,605,000USD | — | — | — | — | — | — |
| Net Interest Income | — | 1,733,000USD | -237,500USD | -4,600USD | -732,500USD | -270,200USD | -256,400USD | -159,500USD |
| Tax Provision | — | 0USD | — | — | — | — | — | — |
| Net Income From Continuing Ops | — | -12,416,000USD | -2,680,400USD | -4,421,800USD | -7,105,600USD | -2,651,700USD | -3,098,700USD | -3,004,100USD |
| Ebit | — | -12,416,000USD | -2,391,400USD | -4,408,600USD | -6,363,300USD | -2,371,100USD | -2,835,500USD | -2,839,400USD |
| Ebitda | — | -11,568,000USD | -2,025,400USD | -4,083,100USD | -6,047,400USD | -2,091,900USD | -2,545,200USD | -2,582,900USD |
| Depreciation And Amortization | — | 848,000USD | 366,000USD | 325,500USD | 315,900USD | 279,200USD | 290,300USD | 256,500USD |
| Reconciled Depreciation | — | 1,281,000USD | 366,000USD | 325,500USD | 315,900USD | 279,200USD | 290,300USD | — |
| Interest Expense | — | — | 289,000USD | 13,200USD | 742,300USD | 280,600USD | 263,200USD | 164,700USD |
| Non Operating Income Net Other | — | — | -237,500USD | -4,600USD | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | -2,680,400USD | -4,421,800USD | -7,105,600USD | -2,875,200USD | -3,098,700USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 9,290,300USD | 7,164,400USD | 6,805,000USD | 5,059,500USD |
| Cost Of Revenue | 1,031,800USD | 957,500USD | 808,600USD | 830,400USD |
| Gross Profit | 8,258,500USD | 6,206,900USD | 5,996,400USD | 4,229,100USD |
| Research Development | 3,008,100USD | 2,490,200USD | 2,215,500USD | 2,206,800USD |
| Selling General Administrative | 2,667,100USD | 2,468,200USD | 2,211,600USD | 2,021,600USD |
| Selling And Marketing Expenses | 3,344,400USD | 2,524,200USD | 2,374,000USD | 1,963,200USD |
| Total Operating Expenses | 9,019,600USD | 7,482,600USD | 6,801,100USD | 6,191,600USD |
| Operating Income | -761,100USD | -1,275,700USD | -804,700USD | -1,962,500USD |
| Interest Expense | 704,400USD | 561,300USD | 153,500USD | 61,700USD |
| Income Before Tax | -1,445,500USD | -1,837,000USD | -958,200USD | -1,988,400USD |
| Income Tax Expense | 724,400USD | — | — | 35,800USD |
| Net Income | -1,445,500USD | -1,837,000USD | -958,200USD | -1,988,400USD |
| Ebit | -741,100USD | -1,275,700USD | -804,700USD | -1,926,700USD |
| Ebitda | -647,800USD | -1,183,700USD | -688,300USD | -1,811,500USD |
| Depreciation And Amortization | 93,300USD | 92,000USD | 116,400USD | 115,200USD |
| Total Other Income Expense Net | -684,400USD | -561,300USD | -153,500USD | -25,900USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 184,672,000USD | 194,473,000USD | 202,507,000USD | 213,476,000USD | 219,750,000USD | 229,961,000USD | 239,470,000USD | 248,612,000USD |
| Cash And Equivalents | 15,042,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 105,690,000USD | 14,557,000USD | 103,044,000USD | 105,728,000USD | 126,562,000USD | 138,270,000USD | 154,482,000USD | 153,832,000USD |
| Short Term Investments | 90,648,000USD | 92,297,000USD | 82,979,000USD | 92,755,000USD | 111,337,000USD | 114,885,000USD | 126,598,000USD | 116,874,000USD |
| Long Term Investments | 36,233,000USD | 40,811,000USD | 52,570,000USD | 52,274,000USD | 38,600,000USD | 36,423,000USD | 35,781,000USD | 42,797,000USD |
| Total Current Assets | 121,274,000USD | 122,937,000USD | 118,369,000USD | 124,645,000USD | 143,219,000USD | 155,748,000USD | 171,684,000USD | 172,909,000USD |
| Other Current Assets | 3,664,000USD | 96,503,000USD | 4,275,000USD | 3,000,000USD | 2,971,000USD | 3,679,000USD | 3,606,000USD | 4,124,000USD |
| Other Non Current Assets | 1,030,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 25,920,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 9,895,000USD | 10,212,000USD | 14,267,000USD | 16,102,000USD | 11,555,000USD | 12,733,000USD | 15,775,000USD | 17,621,000USD |
| Other Non Current Liabilities | 302,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 158,752,000USD | 167,886,000USD | 171,490,000USD | 180,275,000USD | 190,723,000USD | 199,412,000USD | 206,251,000USD | 213,302,000USD |
| Total Equity Including Noncontrolling Interest | 158,752,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 2,463,000USD | — | — | — | — | — | — | — |
| Net Receivables | 3,922,000USD | 4,246,000USD | 3,503,000USD | 8,306,000USD | 5,753,000USD | 5,525,000USD | 4,682,000USD | 4,560,000USD |
| Inventory | 7,798,000USD | 7,631,000USD | 7,547,000USD | 7,611,000USD | 7,933,000USD | 8,274,000USD | 8,914,000USD | 10,393,000USD |
| Property Plant Equipment Net | 25,369,000USD | 27,336,000USD | 28,451,000USD | 29,755,000USD | 30,748,000USD | 31,462,000USD | 30,473,000USD | 31,855,000USD |
| Intangible Assets | 766,000USD | 783,000USD | 650,000USD | 667,000USD | 638,000USD | 498,000USD | — | — |
| Accounts Payable | 1,734,000USD | 1,196,000USD | 1,401,000USD | 1,286,000USD | 1,210,000USD | 2,279,000USD | 1,358,000USD | 1,865,000USD |
| Short Term Debt | 1,528,000USD | 1,374,000USD | 1,456,000USD | 1,314,000USD | 1,308,000USD | 1,276,000USD | 864,000USD | 907,000USD |
| Common Stock | 1,074,000USD | 1,071,000USD | 1,068,000USD | 1,066,000USD | 1,066,000USD | 1,063,000USD | 1,057,000USD | 1,053,000USD |
| Retained Earnings | -275,107,000USD | -266,233,000USD | -261,483,000USD | -251,887,000USD | -239,471,000USD | -227,114,000USD | -216,853,000USD | -206,256,000USD |
| Total Liab | — | 26,587,000USD | 31,017,000USD | 33,201,000USD | 29,027,000USD | 30,549,000USD | 33,219,000USD | 35,310,000USD |
| Other Current Liab | — | 4,371,000USD | 7,812,000USD | 8,306,000USD | 6,397,000USD | 5,033,000USD | 8,302,000USD | 8,196,000USD |
| Capital Stock | — | 1,071,000USD | 1,068,000USD | 1,066,000USD | 1,066,000USD | 1,063,000USD | 1,057,000USD | 1,053,000USD |
| Cash | — | 14,557,000USD | 20,065,000USD | 12,973,000USD | 15,225,000USD | 23,385,000USD | 27,884,000USD | 36,958,000USD |
| Current Deferred Revenue | — | 3,271,000USD | 3,598,000USD | 5,196,000USD | 2,640,000USD | 4,145,000USD | 5,251,000USD | 6,653,000USD |
| Net Debt | — | 2,930,000USD | -2,122,000USD | 5,188,000USD | 3,282,000USD | -4,563,000USD | -9,850,000USD | -18,639,000USD |
| Short Long Term Debt Total | — | 17,487,000USD | 17,943,000USD | 18,161,000USD | 18,507,000USD | 18,822,000USD | 18,034,000USD | 18,319,000USD |
| Property Plant Equipment Gross | — | 45,607,000USD | 45,715,000USD | 46,739,000USD | 47,263,000USD | 47,082,000USD | 44,065,000USD | 31,855,000USD |
| Common Stock Shares Outstanding | — | 106,875,087shares | 106,427,854shares | 106,324,792shares | 106,403,540shares | 105,950,480shares | 104,849,222shares | 105,109,603shares |
| Non Current Assets Total | — | 71,536,000USD | 84,138,000USD | 88,831,000USD | 76,531,000USD | 74,213,000USD | 67,786,000USD | 75,703,000USD |
| Non Current Liabilities Total | — | 16,375,000USD | 16,750,000USD | 17,099,000USD | 17,472,000USD | 17,816,000USD | 17,444,000USD | 17,689,000USD |
| Non Current Liabilities Other | — | 262,000USD | 263,000USD | 252,000USD | 273,000USD | 270,000USD | 274,000USD | 277,000USD |
| Non Currrent Assets Other | — | 2,606,000USD | 2,467,000USD | 2,581,000USD | 2,797,000USD | 1,911,000USD | 1,532,000USD | 1,051,000USD |
| Net Working Capital | — | 112,725,000USD | 104,102,000USD | 108,543,000USD | 131,664,000USD | 143,015,000USD | 155,909,000USD | 155,288,000USD |
| Unclassified Current Assets | — | -92,297,000USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 16,113,000USD | 16,487,000USD | 16,847,000USD | 17,199,000USD | 17,546,000USD | 17,170,000USD | 17,412,000USD |
| Unclassified Equity | — | 431,977,000USD | 430,837,000USD | 430,030,000USD | 428,062,000USD | 424,400,000USD | 420,990,000USD | 417,452,000USD |
| Good Will | — | — | — | 3,554,000USD | 3,748,000USD | 3,919,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 202,507,000USD | 239,470,000USD | 268,274,000USD | 286,653,000USD | 284,120,000USD | 51,780,100USD | 29,985,400USD | 24,267,900USD |
| Intangible Assets | 650,000USD | — | — | — | — | — | — | — |
| Other Current Assets | 4,275,000USD | 3,606,000USD | 3,899,000USD | 5,170,000USD | 3,307,400USD | 1,003,000USD | 797,100USD | 863,700USD |
| Total Liab | 31,017,000USD | 33,219,000USD | 36,107,000USD | 32,685,000USD | 21,222,900USD | 18,554,700USD | 16,383,600USD | 11,986,200USD |
| Total Stockholder Equity | 171,490,000USD | 206,251,000USD | 232,167,000USD | 253,968,000USD | 262,897,100USD | 33,225,400USD | 13,601,800USD | 12,281,700USD |
| Other Current Liab | 7,812,000USD | 8,302,000USD | 11,269,000USD | 14,978,000USD | 6,523,500USD | 5,208,500USD | 3,551,600USD | 2,449,300USD |
| Common Stock | 1,068,000USD | 1,057,000USD | 1,040,000USD | 1,024,000USD | 1,012,000USD | 773,800USD | 574,000USD | 513,300USD |
| Capital Stock | 1,068,000USD | 1,057,000USD | 1,040,000USD | 1,024,000USD | 1,012,000USD | 773,800USD | 574,000USD | 513,300USD |
| Retained Earnings | -261,483,000USD | -216,853,000USD | -175,798,000USD | -137,875,000USD | -114,304,500USD | -95,222,300USD | -83,405,900USD | -70,510,900USD |
| Cash | 20,065,000USD | 27,884,000USD | 46,506,000USD | 11,065,000USD | 47,782,400USD | 18,755,200USD | 15,210,800USD | 11,248,000USD |
| Cash And Short Term Investments | 103,044,000USD | 154,482,000USD | 168,288,000USD | 227,340,000USD | 255,043,800USD | 34,762,700USD | 16,708,600USD | 14,439,000USD |
| Total Current Assets | 118,369,000USD | 171,684,000USD | 190,194,000USD | 252,266,000USD | 270,432,800USD | 45,253,400USD | 24,452,000USD | 22,450,000USD |
| Total Current Liabilities | 14,267,000USD | 15,775,000USD | 17,855,000USD | 15,427,000USD | 15,617,800USD | 11,614,300USD | 9,343,100USD | 6,572,600USD |
| Current Deferred Revenue | 3,598,000USD | 5,251,000USD | 5,069,000USD | 6,712,600USD | 6,746,800USD | 4,843,000USD | 3,193,200USD | 2,449,300USD |
| Net Debt | -2,122,000USD | -9,850,000USD | -27,763,000USD | 5,030,000USD | -42,100,300USD | -11,788,800USD | -7,999,500USD | -6,191,700USD |
| Short Term Debt | 1,456,000USD | 864,000USD | 774,000USD | 157,000USD | 527,200USD | 672,600USD | 508,900USD | 2,449,300USD |
| Short Long Term Debt Total | 17,943,000USD | 18,034,000USD | 18,743,000USD | 16,095,000USD | 5,682,100USD | 6,966,400USD | 7,211,300USD | 5,056,300USD |
| Long Term Investments | 52,570,000USD | 35,781,000USD | 42,938,000USD | 0USD | — | — | — | — |
| Short Term Investments | 82,979,000USD | 126,598,000USD | 121,782,000USD | 216,275,000USD | 207,261,400USD | 16,007,500USD | 1,497,800USD | 3,191,000USD |
| Net Receivables | 3,503,000USD | 4,682,000USD | 5,778,000USD | 11,175,000USD | 6,877,000USD | 5,171,900USD | 3,244,500USD | 4,904,500USD |
| Inventory | 7,547,000USD | 8,914,000USD | 12,229,000USD | 8,581,000USD | 5,204,600USD | 4,315,800USD | 3,701,800USD | 2,242,800USD |
| Accounts Payable | 1,401,000USD | 1,358,000USD | 743,000USD | 292,000USD | 1,820,300USD | 890,200USD | 2,089,400USD | 4,123,300USD |
| Property Plant Equipment Net | 28,451,000USD | 30,473,000USD | 34,754,000USD | 33,578,000USD | 13,370,500USD | 6,492,800USD | 5,533,400USD | 1,817,900USD |
| Property Plant Equipment Gross | 45,715,000USD | 44,065,000USD | 45,040,000USD | 23,724,700USD | 7,681,200USD | 6,492,800USD | 5,533,400USD | 1,817,900USD |
| Common Stock Shares Outstanding | 106,427,854shares | 104,849,000shares | 103,268,502shares | 101,702,664shares | 90,619,057shares | 69,464,751shares | 56,397,524shares | 51,182,402shares |
| Non Current Assets Total | 84,138,000USD | 67,786,000USD | 78,080,000USD | 34,387,000USD | 13,687,200USD | 6,526,700USD | 5,533,400USD | 1,817,900USD |
| Non Current Liabilities Total | 16,750,000USD | 17,444,000USD | 18,252,000USD | 17,258,000USD | 5,605,100USD | 6,940,400USD | 7,040,500USD | 5,413,600USD |
| Non Current Liabilities Other | 263,000USD | 274,000USD | 283,000USD | 1,321,600USD | 450,200USD | 646,600USD | 338,100USD | 357,300USD |
| Non Currrent Assets Other | 2,467,000USD | 1,532,000USD | 388,000USD | 809,000USD | 316,700USD | 33,900USD | -5,533,400USD | — |
| Net Working Capital | 104,102,000USD | 155,909,000USD | 172,339,000USD | 236,839,700USD | 254,815,000USD | 33,639,100USD | 15,108,900USD | 15,877,400USD |
| Unclassified Non Current Liabilities | 16,487,000USD | 17,170,000USD | 17,969,000USD | 14,614,800USD | 4,704,700USD | — | 1,469,000USD | — |
| Unclassified Equity | 430,837,000USD | 420,990,000USD | 405,885,000USD | 389,795,000USD | 375,177,600USD | 126,900,100USD | 95,859,700USD | 81,766,000USD |
| Other Liab | — | — | — | 1,321,600USD | 450,200USD | 646,600USD | 338,100USD | 357,300USD |
| Other Assets | — | — | — | 809,000USD | 316,700USD | 33,900USD | — | — |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | 0USD | — | — | — |
| Net Tangible Assets | — | — | — | 253,967,200USD | 262,897,100USD | 33,225,400USD | 13,601,800USD | 12,281,700USD |
| Unclassified Current Liabilities | — | — | — | -6,712,600USD | — | — | — | -4,898,600USD |
| Long Term Debt | — | — | — | — | — | 4,917,000USD | 4,895,300USD | 5,056,300USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 2,025,000USD |
| Stock Based Compensation | 2,301,000USD |
| Change To Account Receivables | -419,000USD |
| Change To Inventory | -852,000USD |
| Change To Liabilities | -3,237,000USD |
| Change In Working Capital | -3,583,000USD |
| Operating Cash Flow | -12,830,000USD |
| Capital Expenditures | -134,000USD |
| Net Investments | 9,506,000USD |
| Unclassified Investing Cash Flow | -150,000USD |
| Investing Cash Flow | 9,222,000USD |
| Net Common Stock Issuance | -1,478,000USD |
| Unclassified Financing Cash Flow | 63,000USD |
| Financing Cash Flow | -1,415,000USD |
| Change In Cash | -5,023,000USD |
| End Cash Flow | 15,042,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,750,000USD | -9,596,000USD | -12,416,000USD | -12,357,000USD | -10,261,000USD | -10,597,000USD | -11,557,000USD | -9,375,000USD |
| Depreciation | 1,046,999USD | 1,287,000USD | 1,072,000USD | 1,276,000USD | 1,277,000USD | 1,057,000USD | 1,066,000USD | 1,081,000USD |
| Stock Based Compensation | 1,141,000USD | 706,000USD | 1,954,000USD | 3,514,000USD | 3,039,000USD | 3,134,000USD | 3,370,000USD | 3,564,000USD |
| Other Non Cash Items | 1,136,000USD | 3,452,000USD | 1,992,000USD | 3,015,000USD | -772,000USD | 3,430,000USD | 2,915,000USD | 2,247,000USD |
| Change To Account Receivables | -743,000USD | 4,797,000USD | -2,572,000USD | -238,000USD | -839,000USD | -122,000USD | 21,000USD | 1,670,000USD |
| Change To Inventory | -380,000USD | -72,000USD | -107,000USD | 223,000USD | 531,000USD | 527,000USD | 2,000USD | 664,000USD |
| Change In Working Capital | -5,602,000USD | 1,462,000USD | 1,894,000USD | -1,786,000USD | -7,694,000USD | -1,711,000USD | 3,185,000USD | 1,213,000USD |
| Total Cash From Operating Activities | -8,169,000USD | -2,689,000USD | -7,458,000USD | -9,852,000USD | -14,411,000USD | -7,821,000USD | -4,391,000USD | -4,834,000USD |
| Capital Expenditures | -222,000USD | -231,000USD | -300,000USD | -584,000USD | -653,000USD | -147,000USD | -406,000USD | -294,000USD |
| Free Cash Flow | -8,391,000USD | -2,920,000USD | -7,758,000USD | -10,436,000USD | -15,064,000USD | -7,968,000USD | -4,797,000USD | -5,128,000USD |
| Investments | 2,878,000USD | 9,907,000USD | 5,192,000USD | 1,538,000USD | 9,529,000USD | -1,665,000USD | 3,608,000USD | 19,385,000USD |
| Total Cashflows From Investing Activities | 2,656,000USD | 9,676,000USD | 5,192,000USD | 1,538,000USD | 9,529,000USD | -1,665,000USD | 3,608,000USD | 19,385,000USD |
| Total Cash From Financing Activities | 5,000USD | 105,000USD | 14,000USD | 154,000USD | 383,000USD | 412,000USD | 228,000USD | 713,000USD |
| Change In Cash | -5,508,000USD | 7,092,000USD | -2,252,000USD | -8,160,000USD | -4,499,000USD | -9,074,000USD | -555,000USD | 15,264,000USD |
| Begin Period Cash Flow | 20,065,000USD | 12,973,000USD | 15,225,000USD | 23,385,000USD | 27,884,000USD | 36,958,000USD | 37,513,000USD | 22,249,000USD |
| End Period Cash Flow | 14,557,000USD | 20,065,000USD | 12,973,000USD | 15,225,000USD | 23,385,000USD | 27,884,000USD | 36,958,000USD | 37,513,000USD |
| Unclassified Operating Cash Flow | -1,140,999USD | — | -1,954,000USD | -3,514,000USD | — | -3,134,000USD | -3,370,000USD | -3,564,000USD |
| Sale Purchase Of Stock | — | — | 134,000USD | 134,000USD | — | — | 265,000USD | — |
| Other Cashflows From Financing Activities | — | — | 14,000USD | 20,000USD | 383,000USD | 412,000USD | 228,000USD | 713,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 19,679,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -19,385,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -44,630,000USD | -41,055,000USD | -37,923,000USD | -23,570,800USD | -19,082,200USD | -11,816,400USD | -12,895,000USD | -8,869,200USD |
| Depreciation | 5,142,000USD | 4,315,000USD | 4,566,000USD | 2,697,900USD | 1,423,900USD | 1,047,700USD | 613,500USD | 344,000USD |
| Stock Based Compensation | 9,213,000USD | 13,083,000USD | 13,979,000USD | 11,752,000USD | 7,958,800USD | 2,471,800USD | 1,752,100USD | 1,324,200USD |
| Other Non Cash Items | 1,989,000USD | 9,881,000USD | -6,128,000USD | 9,300,900USD | 664,600USD | 373,000USD | 76,900USD | 74,700USD |
| Change To Account Receivables | 1,148,000USD | 1,226,000USD | 7,138,000USD | -6,690,000USD | -1,705,100USD | -1,810,200USD | 1,592,000USD | -1,947,900USD |
| Change To Inventory | 575,000USD | 1,362,000USD | -4,534,000USD | -3,493,300USD | -1,405,800USD | -890,600USD | -1,890,200USD | -1,289,700USD |
| Change In Working Capital | -6,124,000USD | -751,000USD | 3,820,000USD | -3,210,900USD | -1,644,700USD | -858,200USD | 1,612,700USD | -3,457,500USD |
| Total Cash From Operating Activities | -34,410,000USD | -27,610,000USD | -21,686,000USD | -14,782,900USD | -10,679,600USD | -8,782,100USD | -8,802,500USD | -10,487,400USD |
| Capital Expenditures | -1,768,000USD | -1,651,000USD | -3,700,000USD | -18,477,200USD | -3,834,200USD | -2,072,100USD | -1,271,300USD | -709,700USD |
| Free Cash Flow | -36,178,000USD | -29,261,000USD | -25,386,000USD | -33,260,100USD | -14,513,800USD | -10,854,200USD | -10,073,800USD | -11,197,100USD |
| Investments | 29,476,000USD | 6,932,000USD | 32,028,000USD | -6,346,100USD | -191,183,600USD | -14,505,900USD | 1,725,800USD | -3,123,400USD |
| Total Cashflows From Investing Activities | 25,935,000USD | 6,932,000USD | 54,984,000USD | -24,823,300USD | -195,013,200USD | -16,578,000USD | 454,500USD | -3,833,100USD |
| Total Cash From Financing Activities | 656,000USD | 2,056,000USD | 2,143,000USD | 2,888,500USD | 234,720,000USD | 28,904,500USD | 12,310,800USD | 226,800USD |
| Change In Cash | -7,819,000USD | -18,622,000USD | 35,441,000USD | -36,717,700USD | 29,027,200USD | 3,544,400USD | 3,962,800USD | -14,093,700USD |
| Begin Period Cash Flow | 27,884,000USD | 46,506,000USD | 11,065,000USD | 47,782,400USD | 18,755,200USD | 15,210,800USD | 11,248,000USD | 25,341,700USD |
| End Period Cash Flow | 20,065,000USD | 27,884,000USD | 46,506,000USD | 11,064,700USD | 47,782,400USD | 18,755,200USD | 15,210,800USD | 11,248,000USD |
| Unclassified Investing Cash Flow | -1,773,000USD | 1,651,000USD | 26,647,000USD | 6,346,100USD | — | 14,505,901USD | -1,725,800USD | 3,123,400USD |
| Sale Purchase Of Stock | — | 459,000USD | 269,000USD | 2,888,500USD | 239,708,500USD | — | — | — |
| Other Cashflows From Financing Activities | — | 2,056,000USD | 1,874,000USD | 2,885,611,500USD | 3,631,200USD | 401,000USD | 132,700USD | 230,000USD |
| Unclassified Operating Cash Flow | — | -13,083,000USD | — | -11,752,000USD | — | — | — | — |
| Issuance Of Capital Stock | — | — | 269,000USD | 0USD | 236,077,300USD | 28,567,200USD | 12,330,300USD | 0USD |
| Other Cashflows From Investing Activities | — | — | 9,000USD | -6,346,100USD | 4,600USD | -14,505,901USD | 1,725,800USD | -3,123,400USD |
| Change To Liabilities | — | — | — | 687,500USD | 3,994,700USD | 2,040,800USD | 1,956,100USD | 5,200USD |
| Net Borrowings | — | — | — | 0USD | -4,988,500USD | -63,700USD | -152,200USD | -3,200USD |
| Cash And Cash Equivalents Changes | — | — | — | -36,717,700USD | 29,027,200USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | -2,885,611,500USD | -3,631,200USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 3,035,000 | USD | 0001104659-26-060290 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 6,616,000 | USD | 0001104659-26-060290 |
| Q1 2026Quarterly · 2026-03-31 | Product | Assay And Other Service Revenue | 482,000 | USD | 0001104659-26-060290 |
| Q1 2026Quarterly · 2026-03-31 | Product | License | 380,000 | USD | 0001104659-26-060290 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 3,639,000 | USD | 0001104659-26-060290 |
| Q4 2025Quarterly · 2025-12-31 | Geography | International | 3,405,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 3,895,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 11,948,000 | USD | 0001104659-26-034557 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 21,078,000 | USD | 0001104659-26-034557 |
| FY 2025Yearly · 2025-12-31 | Product | Assay And Other Service Revenue | 1,966,000 | USD | 0001104659-26-034557 |
| FY 2025Yearly · 2025-12-31 | Product | License | 300,000 | USD | 0001104659-26-034557 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 18,691,000 | USD | 0001104659-26-034557 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 2,993,000 | USD | 0001104659-25-111396 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 3,836,000 | USD | 0001104659-25-111396 |
| Q3 2025Quarterly · 2025-09-30 | Product | Assay And Other Service Revenue | 650,000 | USD | 0001104659-25-111396 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 3,953,000 | USD | 0001104659-25-111396 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 3,194,000 | USD | 0001558370-25-010554 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 5,313,000 | USD | 0001558370-25-010554 |
| Q2 2025Quarterly · 2025-06-30 | Product | Assay And Other Service Revenue | 310,000 | USD | 0001558370-25-010554 |
| Q2 2025Quarterly · 2025-06-30 | Product | License | 245,000 | USD | 0001558370-25-010554 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 5,269,000 | USD | 0001558370-25-010554 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 2,356,000 | USD | 0001104659-26-060290 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 8,034,000 | USD | 0001104659-26-060290 |
| Q1 2025Quarterly · 2025-03-31 | Product | Assay And Other Service Revenue | 397,000 | USD | 0001104659-26-060290 |
| Q1 2025Quarterly · 2025-03-31 | Product | License | 30,000 | USD | 0001104659-26-060290 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 5,316,000 | USD | 0001104659-26-060290 |
| Q4 2024Quarterly · 2024-12-31 | Geography | International | 3,373,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 5,319,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 5,796,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product And Service Other | 258,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | International | 12,859,000 | USD | 0001104659-26-034557 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 25,768,000 | USD | 0001104659-26-034557 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 21,089,000 | USD | 0001104659-26-034557 |
| FY 2024Yearly · 2024-12-31 | Product | Product And Service Other | 1,126,000 | USD | 0001104659-26-034557 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 3,020,000 | USD | 0001104659-25-111396 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 5,144,000 | USD | 0001104659-25-111396 |
| Q3 2024Quarterly · 2024-09-30 | Product | Assay And Other Service Revenue | 416,000 | USD | 0001104659-25-111396 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 5,196,000 | USD | 0001104659-25-111396 |
| Q2 2024Quarterly · 2024-06-30 | Geography | International | 3,142,000 | USD | 0001558370-25-010554 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 7,287,000 | USD | 0001558370-25-010554 |
| Q2 2024Quarterly · 2024-06-30 | Product | Assay And Other Service Revenue | 229,000 | USD | 0001558370-25-010554 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 4,736,000 | USD | 0001558370-25-010554 |
| Q1 2024Quarterly · 2024-03-31 | Product | Assay And Other Service Revenue | 223,000 | USD | 0001558370-25-007005 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product | 5,361,000 | USD | 0001558370-25-007005 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 8,868,000 | USD | 0001558370-25-002721 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 32,420,000 | USD | 0001558370-25-002721 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 18,600,000 | USD | 0001558370-25-002721 |
| FY 2023Yearly · 2023-12-31 | Product | Product And Service Other | 897,000 | USD | 0001558370-25-002721 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 27,730,000 | USD | 0001558370-24-003001 |
| FY 2022Yearly · 2022-12-31 | Product | Product And Service Other | 1,018,000 | USD | 0001558370-24-003001 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 20,786,800 | USD | 0001558370-23-003911 |
| FY 2021Yearly · 2021-12-31 | Product | Product And Service Other | 784,600 | USD | 0001558370-23-003911 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 14,850,200 | USD | 0001558370-22-004081 |
| FY 2020Yearly · 2020-12-31 | Product | Product And Service Other | 601,300 | USD | 0001558370-22-004081 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 12,917,800 | USD | 0001558370-22-004081 |
| FY 2019Yearly · 2019-12-31 | Product | Product And Service Other | 339,400 | USD | 0001558370-22-004081 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.